Results

• All
• Video
• Audio
• Images

• Most recent

1–3 of 3 results for Stephen R. Russell

• 

  Safety and Durability of Voretigene Neparvovec for Biallelic RPE65-Mediated Inherited Retinal Disease: Phase 3 Results at 8 Years and 9 Years

  Stephen R. Russell, MD

  Annual Meeting Talks

  2024

• 

  3-Year Update for the Phase 3 Voretigene Neparvovec-rzyl Study in Biallelic RPE65 Mutation-Associated Inherited Retinal Disease

  Stephen R. Russell, MD

  Annual Meeting Talks

  2018

• 

  3-Year Update for the Phase 3 Voretigene Neparvovecrzyl Study in Biallelic RPE65 Mutation–Associated Inherited Retinal Disease

  Stephen R. Russell, MD

  Updates from the Field

  2018